Peptinnovate Ltd

Business Services · United Kingdom · 1-10 Employees

View Company Info for Free

Overview

Headquarters

Stevenage Bioscience Catalyst Gunnels Wo...

Phone Number

+44 1438906978

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About Peptinnovate Ltd

Peptinnovate is a drug development company developing a 'first in class' immune regulating therapy for asthma. Its products have the ability to significantly advance the control and management of moderate to severe chronic inflammatory diseases, with the potential for immune regulation and remission. The lead compound, PIN201104, is uniquely safe and efficacious with supporting preclinical data from GSK's gold standard animal model of asthma disease modification. It is currently in Phase 1 clinical development and has potential to be the first Immune Regulating Asthma Drug (IMRAD). Peptinnovate has an experienced management team and board with track record of building shareholder value, and a world renowned scientific advisory board. It is backed by visionary investors led by Metellus Life Sciences, a Swiss-based VC.Explore more
Peptinnovate Ltd's Social MediaPopular SearchesPeptinnovate LtdPeptinnovatePt Innovate LtdSIC Code 87,873NAICS Code 54,541Show more

Peptinnovate Ltd Org Chart

PhoneEmail
AU
United Kingdom flag for contact location.

Operations

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Peptinnovate Ltd your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Peptinnovate Ltd

Compare insights from companies similar to Peptinnovate Ltd, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Peptinnovate Ltd

<$5M
1-10
Private
-
2011
AU
Al UlyatOperations
$8M
11-50
Private
-
1992
N/A
$5.6M
1-10
Private
-
2004
N/A
<$5M
11-50
Private
-
2015
N/A
<$5M
11-50
Private
$179.6M
2011
N/A
<$5M
11-50
Private
-
-
N/A
<$5M
11-50
Public
-
1999
N/A
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Peptinnovate Ltd is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Peptinnovate Ltd is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Peptinnovate Ltd.

Peptinnovate Ltd Tech Stack

A closer look at the technologies used by Peptinnovate Ltd

Top Business Services Companies

Frequently Asked Questions Regarding Peptinnovate Ltd

What is Peptinnovate Ltd's official website?
Peptinnovate Ltd's official website is www.peptinnovate.com
What is Peptinnovate Ltd's Revenue?
Peptinnovate Ltd's revenue is <$5 Million
What is Peptinnovate Ltd's SIC code?
Peptinnovate Ltd's SIC: 87,873
What is Peptinnovate Ltd's NAICS code?
Peptinnovate Ltd's NAICS: 54,541
How many employees does Peptinnovate Ltd have?
Peptinnovate Ltd has 1-10 employees
What industry does Peptinnovate Ltd belong to?
Peptinnovate Ltd is in the industry of: Business Services, Research & Development
What is Peptinnovate Ltd competition?
Peptinnovate Ltd top competitors include: Saint-Gobain, Rexgenero, ImmuPharma, Alizyme
What technology does Peptinnovate Ltd use?
Some of the popular technologies that Peptinnovate Ltd uses are: Microsoft 365, GoDaddy DNS, Sectigo, Microsoft Exchange Online
How do I contact Peptinnovate Ltd?
Peptinnovate Ltd contact info: Phone number: +44 1438906978 Website: www.peptinnovate.com
What does Peptinnovate Ltd do?

Peptinnovate is a drug development company developing a 'first in class' immune regulating therapy for asthma. Its products have the ability to significantly advance the control and management of moderate to severe chronic inflammatory diseases, with the potential for immune regulation and remission. The lead compound, PIN201104, is uniquely safe a... nd efficacious with supporting preclinical data from GSK's gold standard animal model of asthma disease modification. It is currently in Phase 1 clinical development and has potential to be the first Immune Regulating Asthma Drug (IMRAD). Peptinnovate has an experienced management team and board with track record of building shareholder value, and a world renowned scientific advisory board. It is backed by visionary investors led by Metellus Life Sciences, a Swiss-based VC.Read More

What are Peptinnovate Ltd social media links?
Peptinnovate Ltd Linkedin page
Is Peptinnovate Ltd a public company?
Peptinnovate Ltd is private company therefore does not currently have an official ticker symbol
See more information about Peptinnovate Ltd

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.